HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
BOSTON, Jan. 18, 2024 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing […]